Healthcare -
Biotechnology - NASDAQ - NL
$ 20.93
-0.333 %
$ 2.3 B
Market Cap
-8.18
P/E
Price Target
Average
98.28%
Revenue Forecast
Estimate
206.99%
EBIT
Estimate
36.40%
Net Income
Estimate
65.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NewAmsterdam Pharma Company N.V.
Wall Street analysts predict an average 1-year price target for NAMS of $41.5 , with forecasts ranging from
a
low of
$36 to a high of $48 .
NAMS Lowest Price Target
Wall Street Target
36 USD
72.00%
NAMS Average Price Target
Wall Street Target
41.5 USD
98.28%
NAMS Highest Price Target
Wall Street Target
48 USD
129.34%
REVENUE FORECAST
Revenue Forecast Chart NAMS
EBIT FORECAST
EBIT Forecast Chart NAMS
NET INCOME FORECAST
Net Income Chart NAMS